Colinz Laboratories Share Price Gains 2.5% After Q1 Results

July 31, 2026
Posted by: Kunal Singla
Category: News

Colinz Laboratories gains 2.5% to Rs 82.00. Q1 FY27 PAT Q1 FY27 figure not available in public sources reviewed (N/A YoY). Revenue Q1 FY27 figure not available in public sources reviewed (N/A YoY).

The Colinz Laboratories share price gain after Q1 results theme was in focus on Friday, with Colinz Laboratories shares moving 2.5% to Rs 82.00, from a previous close of Rs 80.00, after the company reported its results for the quarter ended June 2026.

Colinz Laboratories reported a profit after tax of Q1 FY27 figure not available in public sources reviewed for Q1 FY27, against not available in the year-ago quarter, a change of N/A. Revenue for the quarter stood at Q1 FY27 figure not available in public sources reviewed, compared with not available a year earlier, a change of N/A.

Click Here – Get Free Investment Predictions

Table of Contents

Colinz Laboratories Q1 FY27 Results: Key Numbers

Metric	Q1 FY27	Q1 FY26	YoY Change
Profit After Tax	Q1 FY27 figure not available in public sources reviewed	not available	N/A
Revenue	Q1 FY27 figure not available in public sources reviewed	not available	N/A

Why Colinz Laboratories Shares Moved 2.5% Today

Check the Univest Screener for sector-linked stocks

Shares moved on results-day trading; detailed Q1 FY27 financial figures for Colinz Laboratories were not available in the public sources reviewed for this article. Investors should refer to the company’s exchange filing on the BSE or NSE for exact numbers.

About Colinz Laboratories

Manufacturer and trader of pharmaceutical formulations spanning ayurvedic, allopathy and nutraceutical products.

Download the Univest iOS App or Univest Android App to track Colinz Laboratories’s stock price and quarterly results.

What to Watch Going Forward

Investors tracking Colinz Laboratories should watch management commentary on demand trends, cost pressures and full-year guidance in the coming quarters, since forward-looking statements often matter as much as the headline quarterly numbers for how the stock trades over the following weeks.

Conclusion

The Colinz Laboratories share price gain after Q1 results move reflects the market’s reaction to the company’s latest quarterly performance. Investors should evaluate the stock against its own growth trajectory and valuation, and consult a SEBI-registered financial advisor before making any investment decision.

Investors continuing to track the Colinz Laboratories share price gain after Q1 results story should watch how the stock trades in the sessions ahead.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).

Frequently Asked Questions on Colinz laboratories share price gain after q1 results

Why did Colinz Laboratories share price gain after Q1 results?

Ans. Colinz Laboratories shares moved 2.5% after the company reported Q1 FY27 profit after tax of Q1 FY27 figure not available in public sources reviewed, a change of N/A from not available a year earlier, on revenue of Q1 FY27 figure not available in public sources reviewed.

What was Colinz Laboratories’s profit in Q1 FY27?

Ans. Colinz Laboratories reported a profit after tax of Q1 FY27 figure not available in public sources reviewed for the quarter ended June 2026, compared with not available in the same quarter a year earlier.

What was Colinz Laboratories’s revenue in Q1 FY27?

Ans. Colinz Laboratories’s revenue for Q1 FY27 stood at Q1 FY27 figure not available in public sources reviewed, compared with not available a year earlier, a change of N/A.

What is Colinz Laboratories’s current share price?

Ans. Colinz Laboratories shares were trading at Rs 82.00 today, gaining 2.5% from the previous close of Rs 80.00.

Should I buy Colinz Laboratories shares after the Q1 results move?

Ans. Investment decisions should be based on individual research and risk appetite; consult a SEBI-registered financial advisor before buying or selling shares after any results-driven move.

Where can I track Colinz Laboratories’s live share price?

Ans. Colinz Laboratories’s live share price and quarterly result updates can be tracked on the Univest platform alongside SEBI-registered research.

After Q1 Results

Author: Kunal Singla

Kunal Singla is the Associate Director - Research at Univest, leading quantitative equity research, intraday trading setups, and derivatives strategy. With 4+ years of experience in Indian equity markets, he combines rigorous quantitative methods with classical technical analysis to build high-conviction research frameworks for retail and advisory clients. He holds an MSc from the Indian Institute of Technology (IIT) Delhi — one of India's most selective institutions — and has completed the Certificate in Quantitative Finance (CQF), a globally recognised programme covering derivatives pricing, risk modelling, machine learning for finance, and advanced portfolio theory. This combination places him in a small group of Indian analysts with both deep academic training in quantitative methods and SEBI-recognised research credentials. Kunal holds seven SEBI-recognised NISM certifications spanning research, derivatives, portfolio management, and securities operations: Series-XV (Research Analyst), Series-XXI-A (Portfolio Managers), Series-XVI (Commodity Derivatives), Series-VIII (Equity Derivatives), Series-VII (SORM), Series-V-A (Mutual Fund Distributors), and Series-I (Currency Derivatives). At Univest — India's SEBI-registered research and advisory platform — Kunal leads research inputs for Pro Lite, Pro Super, Pro Gold, and Pro Commodity advisory services, alongside publishing intraday stock picks on Univest Blogs.